CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer
Clinical trial NCT02074878 · TERMINATED
Trial details
- NCT number
- NCT02074878
- Sponsor
- Mothaffar Rimawi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-05-16
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.